224
Views
83
CrossRef citations to date
0
Altmetric
Review

Oncoproteomics: current trends and future perspectives

&
Pages 401-410 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Ank Reumer, Evelyne Maes, Inge Mertens, William CS Cho, Bart Landuyt, Dirk Valkenborg, Liliane Schoofs & Geert Baggerman. (2014) Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?. Expert Review of Proteomics 11:4, pages 449-463.
Read now
Xia Guo, Guzalnur Abliz, Halidan Reyimu, Feng Zhao, Nafeisha Kadeer, Rukeya Matsidik, Guizhen Wu & Abulizi Abudula. (2012) The association of a distinct plasma proteomic profile with the cervical high-grade squamous intraepithelial lesion of Uyghur women: a 2D liquid-phase chromatography/mass spectrometry study. Biomarkers 17:4, pages 352-361.
Read now
Monika Pietrowska, Joanna Polańska, Anna Walaszczyk, Andrzej Wygoda, Tomasz Rutkowski, Krzysztof Składowski, Łukasz Marczak, Maciej Stobiecki, Michał Marczyk, Andrzej Polański & Piotr Widłak. (2011) Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients. International Journal of Radiation Biology 87:7, pages 711-719.
Read now
Rui Liu, Kui Wang, Kefei Yuan, Yuquan Wei & Canhua Huang. (2010) Integrative oncoproteomics strategies for anticancer drug discovery. Expert Review of Proteomics 7:3, pages 411-429.
Read now
William CS Cho. (2009) Updates in cancer research: insights from the AACR 100th Annual Meeting. Expert Review of Molecular Diagnostics 9:5, pages 411-416.
Read now

Articles from other publishers (77)

Lei Li, Xingguo Song, Guanxuan Chen, Zhe Zhang, Baibing Zheng, Qianru Zhang, Shiwen Wang & Li Xie. (2023) Plasma exosomal protein PLG and SERPINA1 in colorectal cancer diagnosis and coagulation abnormalities. Journal of Cancer Research and Clinical Oncology 149:11, pages 8507-8519.
Crossref
Kakali Purkayastha, Ruby Dhar, Karthikeyan Pethusamy, Tryambak Srivastava, Abhishek Shankar, GouraKishor Rath & Subhradip Karmakar. (2023) The issues and challenges with cancer biomarkers. Journal of Cancer Research and Therapeutics 19:8, pages 20.
Crossref
Nasir Nisar, Suhail Ahmad Mir, Ozaifa Kareem & Faheem Hyder Pottoo. 2023. Proteomics. Proteomics 77 120 .
Jino Affrald R.Shoba Narayan. 2023. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research 1019 1038 .
Shrestha Dutta, Swatilekha Ghosh, Abhishek Mishra & Rajgourab Ghosh. (2022) Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment. Journal of Proteins and Proteomics.
Crossref
Shweta J. Malode & Nagaraj P. Shetti. (2022) New generation biomarkers for the detection of prostate cancer. Biosensors and Bioelectronics: X 12, pages 100250.
Crossref
Tasneem Khan, Mohhammad A. Altamimi, Afzal Hussain, Mohhammad Ramzan, Sumel Ashique, Mohammed R. Alhuzani, Osamah Abdulrahman Alnemer, Tahir Khuroo & Hisham Abdulaziz Alshammari. (2022) Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis. Advances in Cancer Biology - Metastasis 5, pages 100059.
Crossref
Jino Affrald R & Shoba Narayan. 2022. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research 1 21 .
Shivani SharmaNavdeep SinghAmar Deep AnkalgiArti RanaMahendra Singh Ashawat. (2021) A Laconic Review on Liquid Chromatography Mass Spectrometry (LC-MS) Based Proteomics Technology in Drug Discovery. Asian Journal of Pharmaceutical Research, pages 194-201.
Crossref
Sima Singh, Atal A.S. Gill, Manimbulu Nlooto & Rajshekhar Karpoormath. (2019) Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors. Biosensors and Bioelectronics 137, pages 213-221.
Crossref
Małgorzata Ros-Mazurczyk, Karol Jelonek, Michał Marczyk, Franciszek Binczyk, Monika Pietrowska, Joanna Polanska, Rafał Dziadziuszko, Jacek Jassem, Witold Rzyman & Piotr Widlak. (2017) Serum lipid profile discriminates patients with early lung cancer from healthy controls. Lung Cancer 112, pages 69-74.
Crossref
Song Qing, Wuniqiemu Tulake, Mingfang Ru, Xiaohong Li, Reziwanguli Yuemaier, Dilare Lidifu, Aierken Rouzibilali, Axiangu Hasimu, Yun Yang, Reziya Rouziahong, Halmurat Upur & Abulizi Abudula. (2017) Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection. Tumor Biology 39:4, pages 101042831769754.
Crossref
S.A. Karumanchi. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease 555 594 .
Piotr Widlak, Monika Pietrowska, Joanna Polanska, Michal Marczyk, Malgorzata Ros-Mazurczyk, Rafał Dziadziuszko, Jacek Jassem & Witold Rzyman. (2016) Serum mass profile signature as a biomarker of early lung cancer. Lung Cancer 99, pages 46-52.
Crossref
Li Zhou, Qifu Li, Jiandong Wang, Canhua Huang & Edouard C. Nice. (2016) Oncoproteomics: Trials and tribulations. PROTEOMICS - Clinical Applications 10:4, pages 516-531.
Crossref
Shu‐Yi Yin, M. S. Pradeep & Ning‐Sun Yang. 2015. Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods. Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods 453 475 .
Piotr Widlak, Karol Jelonek, Anna Wojakowska, Monika Pietrowska, Joanna Polanska, Łukasz Marczak, Leszek Miszczyk & Krzysztof Składowski. (2015) Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy—A Pilot Study. International Journal of Radiation Oncology*Biology*Physics 92:5, pages 1108-1115.
Crossref
Monika Pietrowska, Karol Jelonek, Joanna Polanska, Anna Wojakowska, Lukasz Marczak, Ewa Chawinska, Aleksanda Chmura, Wojciech Majewski, Leszek Miszczyk & Piotr Widlak. (2015) Partial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome. Proteomes 3:3, pages 117-131.
Crossref
Gul M Mustafa. (2015) Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients. World Journal of Hepatology 7:10, pages 1312.
Crossref
Francesco Salvatore, Claudia Corbo, Marica Gemei & Luigi Del Vecchio. 2015. Biomarkers in Cancer. Biomarkers in Cancer 53 71 .
T. Holand, Y. Riffo-Vasquez, D. Spina, B. O'Connor, F. Woisin, C. Sand, M. Marber, K.B. Bacon, C. Rohlff & C.P. Page. (2014) A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approach. Pulmonary Pharmacology & Therapeutics 27:2, pages 156-163.
Crossref
Francesco Salvatore, Claudia Corbo, Marica Gemei & Luigi Del Vecchio. 2014. Biomarkers in Cancer. Biomarkers in Cancer 1 15 .
You Rim Jeon, Sun Young Kim, Eun Jeong Lee, Yong Nyun Kim, Dong-Young Noh, So Yeon Park & Aree Moon. (2013) Identification of annexin II as a novel secretory biomarker for breast cancer. PROTEOMICS 13:21, pages 3145-3156.
Crossref
Valerie C. Wasinger, Ming Zeng & Yunki Yau. (2013) Current Status and Advances in Quantitative Proteomic Mass Spectrometry. International Journal of Proteomics 2013, pages 1-12.
Crossref
Nina Kočevar, Petra Hudler & Radovan Komel. (2013) The progress of proteomic approaches in searching for cancer biomarkers. New Biotechnology 30:3, pages 319-326.
Crossref
Petra Hudler. 2013. DNA Alterations in Lynch Syndrome. DNA Alterations in Lynch Syndrome 63 83 .
Takao Kamai, Naohisa Tomosugi, Hideyuki Abe, Yasushi Kaji, Tetsunari Oyama & Ken-Ichiro Yoshida. (2012) Protein Profiling of Blood Samples from Patients with Hereditary Leiomyomatosis and Renal Cell Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. International Journal of Molecular Sciences 13:12, pages 14518-14532.
Crossref
Elena López & William C. S. Cho. (2012) Phosphoproteomics and Lung Cancer Research. International Journal of Molecular Sciences 13:12, pages 12287-12314.
Crossref
Anne K. Callesen, Ole Mogensen, Andreas K. Jensen, Torben A. Kruse, Torben Martinussen, Ole N. Jensen & Jonna S. Madsen. (2012) Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review. Journal of Proteomics 75:10, pages 2758-2772.
Crossref
Qiang Lin, Qianqian Peng, Feng Yao, Xu-Feng Pan, Li-Wen Xiong, Yi Wang, Jun-Feng Geng, Jiu-Xian Feng, Bao-Hui Han, Guo-Liang Bao, Yu Yang, Xiaotian Wang, Li Jin, Wensheng Guo & Jiu-Cun Wang. (2012) A Classification Method Based on Principal Components of SELDI Spectra to Diagnose of Lung Adenocarcinoma. PLoS ONE 7:3, pages e34457.
Crossref
Edmond W. K. YoungChorom PakBrad S. KahlDavid T. Yang, Natalie S. CallanderShigeki Miyamoto & David J. Beebe. (2012) Microscale functional cytomics for studying hematologic cancers. Blood 119:10, pages e76-e85.
Crossref
Courtney J. Doyle, Kyle Yancey, Henry A. Pitt, Mu Wang, Kerry Bemis, Michele T. Yip-Schneider, Stuart T. Sherman, Keith D. Lillemoe, Michael D. Goggins & C. Max Schmidt. (2012) The Proteome of Normal Pancreatic Juice. Pancreas 41:2, pages 186-194.
Crossref
Fengwei Tan, Ying Jiang, Nan Sun, Zhaoli Chen, Yongzhuang Lv, Kang Shao, Ning Li, Bin Qiu, Yibo Gao, Baozhong Li, Xiaogang Tan, Fang Zhou, Zhen Wang, Dapeng Ding, Jiwen Wang, Jian Sun, Jie Hang, Susheng Shi, Xiaoli Feng, Fuchu He & Jie He. (2012) Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis. Molecular & Cellular Proteomics 11:2, pages M111.008821.
Crossref
Hai Tao Niu, Zhen Dong, Gang Jiang, Ting Xu, Yan Qun Liu, Yan Wei Cao, Jun Zhao & Xin Sheng Wang. (2011) Proteomics research on muscle-invasive bladder transitional cell carcinoma. Cancer Cell International 11:1.
Crossref
Chibo Liu, Chunqin Pan, Haibao Wang & Liang Yong. (2011) Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma. Tumor Biology 32:6, pages 1139-1145.
Crossref
Margaret Barh, Debmalya Blum & Kenneth MadiganDipali Dhawan & Harish Padh. 2011. OMICS. OMICS 333 358 .
Ying-Jie Xia, Ying-Yu Ma, Xu-Jun He, Hui-Ju Wang, Zai-Yuan Ye & Hou-Quan Tao. (2011) Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival. Human Pathology 42:11, pages 1620-1628.
Crossref
Renyong Guo, Chunqin Pan, Jianmin Shen & Chibo Liu. (2010) New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Journal of Cancer Research and Clinical Oncology 137:3, pages 513-519.
Crossref
Angelo Gámez-Pozo, Iker Sánchez-Navarro, Enrique Calvo, Esther Díaz, María Miguel-Martín, Rocío López, Teresa Agulló, Emilio Camafeita, Enrique Espinosa, Juan Antonio López, Manuel Nistal & Juan Ángel Fresno Vara. (2011) Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches. Molecular BioSystems 7:8, pages 2368.
Crossref
Ana Sofia Cerdeira & S. Ananth Karumanchi. 2011. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease 385 426 .
William Chi-Shing Cho. 2011. Encyclopedia of Cancer. Encyclopedia of Cancer 3096 3099 .
Yoshio Araki, Kazuhiro Yoshikawa, Sho Okamoto, Masaki Sumitomo, Mikio Maruwaka & Toshihiko Wakabayashi. (2010) Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS. BMC Neurology 10:1.
Crossref
Elfriede Simon. (2010) Biological and chemical sensors for cancer diagnosis. Measurement Science and Technology 21:11, pages 112002.
Crossref
Ajay Matta, Ranju Ralhan, Leroi V. DeSouza & K.W. Michael Siu. (2010) Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery. Mass Spectrometry Reviews 29:6, pages 945-961.
Crossref
Chafika Mazouni, Keith Baggerly, David Hawke, Spyros Tsavachidis, Fabrice André, Aman U. Buzdar, Pierre‐Marie Martin, Ryuji Kobayashi & Lajos Pusztai. (2010) Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2‐positive breast cancer using an LC‐MALDI‐TOF/MS procedure. PROTEOMICS 10:19, pages 3525-3532.
Crossref
Li-Ching Wu, Hsin-Hao Chen, Jorng-Tzong Horng, Chen Lin, Norden E. Huang, Yu-Che Cheng & Kuang-Fu Cheng. (2010) A Novel Preprocessing Method Using Hilbert Huang Transform for MALDI-TOF and SELDI-TOF Mass Spectrometry Data. PLoS ONE 5:8, pages e12493.
Crossref
Petra Hudler, Masa Gorsic & Radovan Komel. (2010) Proteomic strategies and challenges in tumor metastasis research. Clinical & Experimental Metastasis 27:6, pages 441-451.
Crossref
W C S Cho, T T Yip, W W Cheng & J S K Au. (2010) Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis. British Journal of Cancer 102:12, pages 1731-1735.
Crossref
William C. S. Cho. 2010. Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy, and Prognosis 21 40 .
Humberto González-Díaz, Giulio Ferino, Francisco J. Prado-Prado, Santiago Vilar, Eugenio Uriarte, Alejandro Pazos & Cristian R. Munteanu. 2010. An Omics Perspective on Cancer Research. An Omics Perspective on Cancer Research 125 140 .
William C. S. Cho. 2010. An Omics Perspective on Cancer Research. An Omics Perspective on Cancer Research 1 9 .
Seamus M McHugh, Jill O'Donnell & Peter Gillen. (2009) Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World Journal of Surgical Oncology 7:1.
Crossref
Joydeep Mukherjee, Leroi V. DeSouza, Johann Micallef, Zia Karim, Sid Croul, K.W. Michael Siu & Abhijit Guha. (2009) Loss of Collapsin Response Mediator Protein1, as Detected by iTRAQ Analysis, Promotes Invasion of Human Gliomas Expressing Mutant EGFRvIII. Cancer Research 69:22, pages 8545-8554.
Crossref
Huixin Yao, Zhiqiang Zhang, Zhiqiang Xiao, Yongheng Chen, Cui li, Pengfei Zhang, Meixiang Li, Yingfu Liu, Yongjun Guan, Yanhui Yu & Zhuchu Chen. (2009) Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65:1, pages 41-48.
Crossref
Niroshini J Nirmalan, Patricia Harnden, Peter J Selby & Rosamonde E Banks. (2009) Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. The Journal of Pathology 217:4, pages 497-506.
Crossref
Qiaojia Huang, Qingling Huang, Wannan Chen, Lin Wang, Wansong Lin, Jianyin Lin & Xu Lin. (2008) Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. Journal of Cancer Research and Clinical Oncology 134:11, pages 1219-1227.
Crossref
Aaron P. Brown, Deborah E. Citrin & Kevin A. Camphausen. (2008) Clinical biomarkers of angiogenesis inhibition. Cancer and Metastasis Reviews 27:3, pages 415-434.
Crossref
Neesha Dhani & Lillian L. Siu. (2008) Clinical trials and biomarker development with molecularly targeted agents and radiotherapy. Cancer and Metastasis Reviews 27:3, pages 339-349.
Crossref
William C. S. Cho. (2008) Latest Discoveries and Trends in Translational Cancer Research: Highlights of the 2008 Annual Meeting of the American Association for Cancer Research. Technology in Cancer Research & Treatment 7:4, pages 269-277.
Crossref
Kewal K. Jain. (2008) Innovations, challenges and future prospects of oncoproteomics. Molecular Oncology 2:2, pages 153-160.
Crossref
Carol B Fowler, Timothy J O'Leary & Jeffrey T Mason. (2008) Modeling formalin fixation and histological processing with ribonuclease A: effects of ethanol dehydration on reversal of formaldehyde cross-links. Laboratory Investigation 88:7, pages 785-791.
Crossref
P. Schubert & D. V. Devine. (2008) The application of proteomics to blood banking. ISBT Science Series 3:1, pages 30-36.
Crossref
Anne K. Callesen, Werner Vach, Per E. Jørgensen, Søren Cold, Ole Mogensen, Torben A. Kruse, Ole N. Jensen & Jonna S. Madsen. (2008) Reproducibility of Mass Spectrometry Based Protein Profiles for Diagnosis of Breast Cancer across Clinical Studies: A Systematic Review. Journal of Proteome Research 7:4, pages 1395-1402.
Crossref
WCS Cho. (2008) Report of the 10th Annual Meeting of the Chinese Society of Clinical Oncology. Journal of Chinese Integrative Medicine, pages 324-330.
Crossref
Jens Rauch & Olivier Gires. (2008) SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification. PROTEOMICS – Clinical Applications 2:3, pages 355-371.
Crossref
Markus J. Riemenschneider & Guido Reifenberger. 2008. Neural Degeneration and Repair. Neural Degeneration and Repair 209 228 .
W.C. Cho. (2008) A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research. Annals of Oncology 19:2, pages 205-211.
Crossref
Carol B Fowler, Robert E Cunningham, Timothy J Waybright, Josip Blonder, Timothy D Veenstra, Timothy J O'Leary & Jeffrey T Mason. (2007) Elevated hydrostatic pressure promotes protein recovery from formalin-fixed, paraffin-embedded tissue surrogates. Laboratory Investigation 88:2, pages 185-195.
Crossref
Christopher J. Johnson, Nikolay Zhukovsky, Anthony E. G. Cass & Judit M. Nagy. (2008) Proteomics, nanotechnology and molecular diagnostics. PROTEOMICS 8:4, pages 715-730.
Crossref
Yuqiao ShenNeil N. SenzerJohn J. Nemunaitis. (2008) Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy. Drug Target Insights 3, pages DTI.S649.
Crossref
Niroshini J. Nirmalan, Patricia Harnden, Peter J. Selby & Rosamonde E. Banks. (2008) Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Molecular BioSystems 4:7, pages 712.
Crossref
Jon Jones & Allan J. Pantuck. (2008) Genomics and proteomics in renal cell carcinoma: Diagnosis, prognosis, and treatment selection. Current Urology Reports 9:1, pages 9-14.
Crossref
William C.S. Cho. (2007) Proteomic approaches to cancer target identification. Drug Discovery Today: Therapeutic Strategies 4:4, pages 245-250.
Crossref
Jian-Ting Zhang & Yang Liu. (2007) Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment. Cancer Treatment Reviews 33:8, pages 741-756.
Crossref
William Chi-Shing Cho. (2007) Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomedicine & Pharmacotherapy 61:9, pages 515-519.
Crossref
William Chi-Shing Cho. (2012) Application of Proteomics in Chinese Medicine Research. The American Journal of Chinese Medicine 35:06, pages 911-922.
Crossref
William C.S. Cho. (2007) Proteomics Technologies and Challenges. Genomics, Proteomics & Bioinformatics 5:2, pages 77-85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.